FDA fast-tracks Pfizer and Lilly's tanezumab

The drug does not feature in Amgen's pipeline chart. Meanwhile Pfizer and Lilly's other main rivals in the race to develop NGF inhibitors for pain - Teva and Regeneron - suffered ... Later in the year Regeneron said it was preparing for phase III testing

Novartis tie-up with IBM Watson Health in breast cancer

Will combine real-world patient data and cognitive computing

'Nothing about us without us'

As Ruth Wilson, global patient relations and advocacy at Teva, said at the 2016 eyeforpharma Europe summit on patient engagement: “Patients told us: if we are the end product, we should ... be partners at the beginning, not the just the end.”Teva is

Finalists 2017

by Porter Novelli. for Teva UK. UK TMA Preceptorship 2016. by Real Science.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 5)